Hyperfine, Inc. (HYPR)
| Market Cap | 83.53M |
| Revenue (ttm) | 11.69M |
| Net Income (ttm) | -41.93M |
| Shares Out | 72.01M |
| EPS (ttm) | -0.59 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 62,312 |
| Open | 1.170 |
| Previous Close | 1.150 |
| Day's Range | 1.150 - 1.182 |
| 52-Week Range | 0.761 - 3.150 |
| Beta | 0.84 |
| Analysts | Buy |
| Price Target | 2.12 (+82.76%) |
| Earnings Date | Aug 8, 2024 |
About HYPR
Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut. [Read more]
Financial Performance
In 2023, Hyperfine's revenue was $11.03 million, an increase of 61.90% compared to the previous year's $6.81 million. Losses were -$44.24 million, -39.54% less than in 2022.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for HYPR stock is "Buy." The 12-month stock price forecast is $2.12, which is an increase of 82.76% from the latest price.
News
Hyperfine Announces FDA Clearance of Software Update That Enables Faster Acquisition of Best-in-Class Ultra-Low-Field Brain Images
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces FDA clearance of software update that enables faster acquisition of best-in-class ultra-low-field Brain Images.
Hyperfine, Inc. to Announce Second Quarter 2024 Financial Results on August 8, 2024
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to announce second quarter 2024 financial results on August 8, 2024.
Hyperfine Expands European Market Reach with Additional Strategic Distributor Partners
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine expands European market reach with additional strategic distributor partners.
Clinical Research Using Swoop® System for Alzheimer's Disease Monitoring to be Presented at the 2024 Alzheimer's Association International Conference
GUILFORD, Conn.--(BUSINESS WIRE)--Clinical research using Swoop® system for Alzheimer's disease monitoring to be presented at the 2024 AAIC.
Hyperfine, Inc. to Host Analyst and Investor Education Webcast with Clinical and Brain Imaging Experts on June 25, 2024
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to host analyst and investor education webcast with clinical and brain imaging experts on June 25, 2024.
Hyperfine, Inc. Continues Global Market Expansion by Entering Into a Distribution Partnership with Radiosurgery Global, Ltd. to Bring the Swoop® System to India
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. continues global expansion by entering into distribution partnership with Radiosurgery Global, Ltd. to bring Swoop® system to India.
Hyperfine, Inc. to Present at the Jefferies Global Healthcare Conference
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to present at the Jefferies Global Healthcare Conference.
Hyperfine, Inc. Celebrates ASNR 2024
LAS VEGAS--(BUSINESS WIRE)--The 2024 ASNR Annual Meeting had a strong focus on Alzheimer's disease care and growing excitement about ultra-low-field MRI.
Hyperfine, Inc. Reports First Quarter 2024 Financial Results
GUILFORD, Conn., May 13, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magn...
Hyperfine, Inc. to Expand Global Market Reach with Appointment of International Distributors in Key European Markets
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to expand global market reach with appointment of international distributors in key European markets.
Hyperfine, Inc. to Announce First Quarter 2024 Financial Results on May 13, 2024
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to announce first quarter 2024 financial results on May 13, 2024.
Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. at ISMRM with 17 abstracts assessing the potential of using Swoop® System images across multiple care settings and clinical conditions.
Leading Institutions Enroll First Alzheimer's Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
GUILFORD, Conn.--(BUSINESS WIRE)--Leading institutions enroll first Alzheimer's patients receiving amyloid-targeting therapy in CARE PMR study.
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable ma...
Hyperfine, Inc. Collaborates with King's College London to Demonstrate the Swoop® System and UNITY Project to The Princess Royal
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. collaborates with King's College London to demonstrate the Swoop® system and UNITY Project to The Princess Royal.
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to announce fourth quarter and full year 2023 financial results on March 21, 2024.
Hyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare Conference
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to present at the Oppenheimer 34th Annual Healthcare Conference.
Hyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes
GUILFORD, Conn. & ORLANDO, Fla.--(BUSINESS WIRE)--Hyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes.
Hyperfine, Inc. Celebrates Breadth of Swoop® System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational Study
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. presents data at 2024 International Stroke Conference and provides an update on enrollment in ACTION PMR stroke observational study.
Hyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of Use
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. launches AI-powered brain imaging software for enhanced image quality and ease of use.
Hyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces presentations on clinical advancements at RSNA 2023.
Hyperfine, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to present at the Piper Sandler 35th annual healthcare conference.
Hyperfine, Inc. Reports Third Quarter 2023 Financial Results
GUILFORD, Conn., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world's first FDA-cleared, portab...
Observational Study Finds That Hyperfine, Inc. Portable MR Brain Imaging System Assists Clinicians in Early Detection of Acute Brain Injury in ECMO Patients
GUILFORD, Conn.--(BUSINESS WIRE)--Observational study finds that Hyperfine, Inc. portable MR brain imaging system assists clinicians in early detection of ABI in ECMO patients.
Hyperfine, Inc. to Announce Third Quarter Financial Results on November 9, 2023
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to announce third quarter financial results on November 9, 2023.